Gram-negative septic shock: the new approach.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use; D001795:Blood Pressure Determination; D002746:Chlorpromazine / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004716:Endometritis / Q000150:complications; D004754:Enterobacter; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D007036:Hypothermia, Induced; D007545:Isoproterenol / Q000627:therapeutic use*; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D011645:Puerperal Infection / Q000150:complications; D012772:Shock, Septic / Q000188:drug therapy*; D012964:Sodium / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D003911:Dextrans; D007612:Kanamycin; D012964:Sodium; D007545:Isoproterenol; D002746:Chlorpromazine; D006854:Hydrocortisone